Skip to content

Metabolomics approach for clinical study on gastric and colon cancer tumor biomarker screening

Metabolomics approach for clinical study on gastric and colon cancer tumor biomarker screening

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018083
Enrollment
Unknown
Registered
2018-08-29
Start date
2018-08-21
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric and colon cancer

Interventions

Sponsors

The Second Hospital of Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Subjects must meet all of the following inclusion criteria before they can be enrolled: 1. Aged 18-75 years old, male or female; 2. Patients who have been treated initially have not undergone systemic anti-tumor treatment; 3. The subject reads and fully understands the patient's instructions and signs the informed consent form; 4. Patients with clinical symptoms admitted to the hospital, suspected of gastric cancer or colon cancer or diagnosed as primary or colon cancer but no obvious metastasis; 5. Patients who have not received radiotherapy or chemotherapy ; 6. Patients who have not undergone surgery.

Exclusion criteria

Exclusion criteria: If any of the items does not match, the subject cannot be enrolled: 1. Patients with other malignant tumors; 2. Patients with severe systemic diseases; 3. Patients who have received radiotherapy or chemotherapy; 4. Patients during pregnancy.

Design outcomes

Primary

MeasureTime frame
Tumor biomarker;

Countries

China

Contacts

Public ContactGuodong Song

The Second Hospital of Tianjin Medical University

770360621@qq.com+86 13702065567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026